1: Grottick AJ, Whelan K, Sanabria EK, Behan DP, Morgan M, Sage C. Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat. Psychopharmacology (Berl). 2015 Jun;232(11):1973-82. doi: 10.1007/s00213-014-3829-2. Epub 2014 Dec 20. PubMed PMID: 25524140; PubMed Central PMCID: PMC4425807.
2: Dempsie Y, MacRitchie NA, White K, Morecroft I, Wright AF, Nilsen M, Loughlin L, Mair KM, MacLean MR. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension. Cardiovasc Res. 2013 Jul 1;99(1):24-34. doi: 10.1093/cvr/cvt064. Epub 2013 Mar 20. PubMed PMID: 23519266; PubMed Central PMCID: PMC3687748.
3: Quednow BB, Treyer V, Hasler F, Dörig N, Wyss MT, Burger C, Rentsch KM, Westera G, Schubiger PA, Buck A, Vollenweider FX. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography. Neuroimage. 2012 Feb 15;59(4):3922-32. doi: 10.1016/j.neuroimage.2011.09.045. Epub 2011 Oct 5. PubMed PMID: 21996132.
4: Mahendran R. Acute manic relapse with dexfenfluramine. Clin Psychopharmacol Neurosci. 2011 Apr;9(1):44. doi: 10.9758/cpn.2011.9.1.44. Epub 2011 Apr 30. PubMed PMID: 23431324; PubMed Central PMCID: PMC3568654.
5: Banas SM, Doly S, Boutourlinsky K, Diaz SL, Belmer A, Callebert J, Collet C, Launay JM, Maroteaux L. Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects. Neuropsychopharmacology. 2011 Jan;36(2):423-33. doi: 10.1038/npp.2010.173. Epub 2010 Oct 6. PubMed PMID: 20927048; PubMed Central PMCID: PMC3055663.
6: Bouffioux L, Radermecker MA, De Leval L, D'Orio V, Limet R. [Image of the month. A case of aortic regurgitation association with dexfenfluramine]. Rev Med Liege. 2009 Sep;64(9):432-3. French. PubMed PMID: 19947311.
7: Desbuards N, Antier D, Rochefort GY, Apfeldorfer CS, Schenck E, Hanton G, Hyvelin JM. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension. Eur J Pharmacol. 2009 Jan 14;602(2-3):355-63. doi: 10.1016/j.ejphar.2008.11.025. Epub 2008 Nov 21. PubMed PMID: 19049806.
8: Dempsie Y, Morecroft I, Welsh DJ, MacRitchie NA, Herold N, Loughlin L, Nilsen M, Peacock AJ, Harmar A, Bader M, MacLean MR. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Circulation. 2008 Jun 3;117(22):2928-37. doi: 10.1161/CIRCULATIONAHA.108.767558. Epub 2008 May 27. PubMed PMID: 18506000.
9: Foltin RW, Danysz W, Bisaga A. A novel procedure for assessing the effects of drugs on satiation in baboons: effects of memantine and dexfenfluramine. Psychopharmacology (Berl). 2008 Sep;199(4):583-92. doi: 10.1007/s00213-008-1178-8. Epub 2008 May 15. PubMed PMID: 18481045; PubMed Central PMCID: PMC2708070.
10: Wellman PJ. Effects of acute administration of phentermine, alone or in combination with dexfenfluramine, on pain reactivity in the adult rat. Pharmacol Biochem Behav. 2008 Sep;90(3):339-43. doi: 10.1016/j.pbb.2008.03.009. Epub 2008 Mar 25. PubMed PMID: 18462783.